We welcome you to propose a new health condition for a screening programme that is not already considered by the UK NSC.
Please download the form and read the guidance at the end of this link to make a proposal.
The deadline for submissions is 16th December 2018. For more information please see this blog.
The UK NSC recommendation on Cystic fibrosis screening in pregnancy (currently under review)
Find general information about population health screening. More about Cystic Fibrosis (pregnancy)Cystic Fibrosis (CF) was recognised as a specific entity by Dorothy Andersen of New York in 1938. The condition is characterised by early onset of severe intestinal malabsorption, failure to thrive and recurrent chest infections and pneumonia which, if untreated, leads to death from malnutrition and respiratory failure in infancy or early childhood. Due to improved treatment, particularly with antibiotics and better pancreatic enzyme replacement therapy, average survival has steadily improved to around 37 years. » Read more about cystic fibrosis on NHS Choices Stakeholders • Cystic Fibrosis Trust The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process. More optionsGo to top | ||||
